Alisertib: a review of pharmacokinetics, efficacy and toxicity in patients with hematologic malignancies and solid tumors

JOURNAL ARTICLE published 2 January 2018 in Expert Opinion on Investigational Drugs

Authors: Susanne Liewer | Ashley Huddleston